GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Venture Life Group PLC (LSE:VLG) » Definitions » ROE % Adjusted to Book Value

Venture Life Group (LSE:VLG) ROE % Adjusted to Book Value : 11.55% (As of Dec. 2023)


View and export this data going back to 2014. Start your Free Trial

What is Venture Life Group ROE % Adjusted to Book Value?

Venture Life Group's ROE % for the quarter that ended in Dec. 2023 was 6.47%. Venture Life Group's PB Ratio for the quarter that ended in Dec. 2023 was 0.56. Venture Life Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 11.55%.


Venture Life Group ROE % Adjusted to Book Value Historical Data

The historical data trend for Venture Life Group's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Venture Life Group ROE % Adjusted to Book Value Chart

Venture Life Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.24 2.78 6.37 1.15 2.16

Venture Life Group Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.37 -1.11 3.30 -6.20 11.55

Competitive Comparison of Venture Life Group's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, Venture Life Group's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Venture Life Group's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Venture Life Group's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Venture Life Group's ROE % Adjusted to Book Value falls into.



Venture Life Group ROE % Adjusted to Book Value Calculation

Venture Life Group's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=1.21% / 0.56
=2.16%

Venture Life Group's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=6.47% / 0.56
=11.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Venture Life Group ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Venture Life Group's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Venture Life Group (LSE:VLG) Business Description

Traded in Other Exchanges
N/A
Address
Eastern Road, 12 The Courtyard, Bracknell, Berkshire, GBR, RG12 2XB
Venture Life Group PLC is an international consumer self-care company. The company focuses on the development and commercialization of healthcare products, including oral care products, food supplements, medical devices, and dermo-cosmetics for the aging population. The company operates in two segments: Venture Life Brands, which includes sales of branded healthcare and cosmetics products, and Customer Brands, which includes sales of products and services under contract development and manufacturing agreements. Its geographical segments include the United Kingdom, Italy, Switzerland, Germany, Netherlands, the Rest of Europe, China, and the Rest of the World.

Venture Life Group (LSE:VLG) Headlines

No Headlines